Clinuvel Pharmaceuticals Limited

CLVLF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income$22$14$25$11
Dep. & Amort.$1$1$1$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$1$0$6
Change in WC$0$0-$5$0
Other Non-Cash$5-$3-$10$9
Operating Cash Flow$28$13$11$26
Investing Activities
PP&E Inv.-$0-$0-$0-$5
Net Acquisitions$0$0$0$0
Inv. Purchases-$17$0$0-$11
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0-$30-$13$0
Investing Cash Flow-$18-$30-$13-$16
Financing Activities
Debt Repay.$0-$0$0-$0
Stock Issued$0$0$0$0
Stock Repurch.-$0-$0-$5$0
Dividends Paid-$0-$3$0-$2
Other Fin. Act.$0$0$4$0
Financing Cash Flow$0-$3-$1-$3
Forex Effect$1$1-$0-$0
Net Chg. in Cash$11$17-$4$15
Supplemental Information
Beg. Cash$17$0$39$24
End Cash$28$17$35$39
Free Cash Flow$28$13$10$21
Clinuvel Pharmaceuticals Limited (CLVLF) Financial Statements & Key Stats | AlphaPilot